透明细胞癌

tòu mínɡ xì bāo ái
  • clear cell cancer
透明细胞癌透明细胞癌
  1. 目的研究低氧诱导因子(HIF)-1α和-2αmRNA在肾透明细胞癌中的表达及其临床意义。

    Purpose To investigate the clinical value of hypoxia inducible factor-1 α( HIF-1 α) mRNA and hypoxia inducible factor-2 α( HIF-2 α) mRNA expression in renal clear cell cancer ( RCCC ) .

  2. 结果66例肾透明细胞癌HIF-2α阳性率为68.2%,其表达随TNM分期的升高而增加(P<0.01)。

    Results in 66 cases of renal clear cell cancer , the posi - tive rate of HIF-2 α was 68.2 % . HIF-2 α expression increased as TNM stage increased ( P < 0.01 ) .

  3. 肾透明细胞癌强化程度的CT评估价值

    Evaluating value of spiral CT in enhanced-degree of renal clear cell carcinoma

  4. 肾透明细胞癌CT灌注成像特点的研究

    Preliminary Study of the CT Perfusion Imaging Features in Clear Cell Carcinoma of Kidney

  5. 肾透明细胞癌克隆起源的X染色体失活类型研究

    Clonal Origin Study of Clear Cell Renal Carcinoma by X-chromosome Inactivation Pattern

  6. 肾透明细胞癌的CT、MRI诊断

    CT and MRI diagnosis of renal clear cell carcinoma

  7. 肾透明细胞癌的CT表现与癌细胞核DNA含量的关系

    Study on the correlation between CT appearance and nuclear DNA content in renal clear cell carcinomas

  8. 白细胞介素1β转换酶(ICE)在肾透明细胞癌中的表达

    Expression of Interleukin - 1 β Converting Enzyme in Renal Clear Cell Carcinoma

  9. 早期肾透明细胞癌的超声、CT和MRI诊断

    US 、 CT 、 MRI Diagnosis of Renal Clear Cell Carcinoma in the early Stege

  10. 肾透明细胞癌与HLA抗原关系的初步研究

    Analysis of the relationship between HLA antigens and renal cell carcinoma

  11. 结果:DNA指数均值以肉瘤样癌最大,透明细胞癌最小(P<0.05)。

    Results : The average DNA index value was the highest in sarcomatoid carcinomas and lowest in clear cell carcinomas ( P 0.05 ) .

  12. 细胞凋亡调控基因bcl-2和bax在肾透明细胞癌组织中的表达及意义

    Expression and Significance of Apoptosis-regulatory Genes bcl-2 and Bax in Renal Clear Cell Carcinoma

  13. 2.76.36%的肾癌为透明细胞癌,肾癌在CT增强扫描上呈中度和显著强化者占90.91%。

    76.36 % RCC were clear cell carcinomas , 90.91 % tumors possed envelope indifferent lesions shown medium or obvious enhancement on CT scanning .

  14. PCNA、T和Th淋巴细胞在肾透明细胞癌的表达与预后的关系

    PCNA , T and Th lymphocyte expression in the prognosis of renal clear cell carcinoma

  15. 静脉联合应用低剂量IL-2和中等剂量IFN(α-2b)治疗肾透明细胞癌的初步探讨

    Intravenous infusion low-dose interleukin-2 and middle-dose interferon-2b for the treatment of patients with renal cell carcinoma

  16. 1例PET检查结果为阴性者,B超及CT检查均为阳性,病理证实为透明细胞癌复发。

    One case was negative by PET but positive by B-ultrasound and CT examination , and the pathology revealed ovarian clear cell carcinoma recurrence .

  17. 螺旋CT鉴别透明细胞癌与非透明细胞癌的准确性在皮髓质期、肾实质期、排泄期分别为93.5%、86.9%、81.5%。

    Accuracy of CT for differentiating clear cell and non-clear cell carcinoma in three enhanced phases was 93.5 % , 86.9 % and 81.5 % , respectively .

  18. 肾透明细胞癌中PCNA和T淋巴细胞的免疫组化研究

    Influence of Expression of PCNA and T Lymphocyte on Prognosis in Patients with Renal Clear Cell Carcinoma

  19. CyclinT1与β-catenin在肾透明细胞癌中的表达及意义

    Expression and roles of cyclin T1 and β - catenin in renal clear cell carcinoma

  20. 肾透明细胞癌中Ki-67指数、EGFR表达及DNA倍体的临床意义

    The clinical significance of Ki-67 label index , EGFR expression and DNA aneuploid in clear cell type renal cell carcinoma

  21. 目的探讨儿童肾透明细胞癌病理形态特点及癌细胞DNA含量和倍体的关系。

    Objective To investigate the pathological features of renal clear cell carcinoma ( RCCC ) in children and its relationship to the DNA content of cancer cells and DNA ploidy .

  22. 增强时肾透明细胞癌的皮质期、实质期和排泄期实性成分平均CT值明显高于乳头状癌和嫌色细胞癌。

    The average CT value of clear cell carcinoma was significantly higher than that of papillary carcinoma and chromophobe carcinoma in corticomedullary , nephrographic and excretory phase by enhancement scan .

  23. 盐酸依立替康(CPT-11)与丝裂霉素C可作为卵巢透明细胞癌的一线化疗药

    Irinotecan hydrochloride ( CPT-11 ) and mitomycin C as the first line chemotherapy for ovarian clear cell adenocarcinoma

  24. 人肾透明细胞癌中ki-67bcl-2Baxp53表达及癌细胞自发凋亡率的临床意义

    Clinical significance of the expression of ki-67 , bcl-2 , bax , p53 and the spontaneous apoptosis in human renal clear cell carcinoma

  25. 本实验将通过研究女性肾透明细胞癌及正常肾组织的X染色体失活类型判断肾透明细胞癌克隆起源。

    To assess the clonal origin of renal clear cell carcinomas by the study of X-chromosome inactivation pattern in female clear cell renal carcinomas and normal renal tissues .

  26. 【方法】报道经手术与病理证实的原发性肺透明细胞癌5例,并结合文献病例对其X线与CT表现进行了分析。

    Five cases with PCC of the lung were confirmed by operation and pathological examination , their X-ray and CT manifestations were analyzed retrospectively in combination with those cases reported on literatures .

  27. p53基因改变在卵巢透明细胞癌的发生与发展中不起关键作用,此点区别于其他卵巢肿瘤。

    The mutation of p53 gene is not crucial in onset and development of clear cell carcinoma , which is different from other ovary cancer .

  28. 方法收集61例肾透明细胞癌组织及10例正常肾组织,以半定量RT-PCR方法,检测了其中32例肾透明细胞癌中SURVIVINMRNA表达水平;

    Methods 61 RCCC specimens and 10 nomal nephridial tissues were obtained . Semiquantitative RT-PCR method was used to detect mRNA expression of Survivin ;

  29. 目的检测抗凋亡基因survivin在肾透明细胞癌中的表达情况及其与肾透明细胞癌生物学特性的关系。

    Objective To detect the expression of survivin in suprarenal epithelioma ( SRE ) and elucidate its function in suprarenal epithelioma .

  30. 腹膜内~(32)P放射治疗和阴道近距离放射治疗作为子宫内膜浆液性乳头状癌和透明细胞癌的辅助治疗:一项Ⅱ期印第安肿瘤学会(HOG97-01)研究

    Intraperitoneal radioactive phosphorus ( ~ ( 32 ) P ) and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma : A phase II Hoosier Oncology Group ( HOG 97 - 01 ) study